Prediction: Palantir Sell-Off Could Be a Buying Opportunity, but With One Major Caveat

In This Article:

Key Points

  • Palantir shares sank despite a strong quarter of accelerating revenue growth.

  • The stock's valuation and weak results in Europe were behind the decline.

  • The company, however, has an opportunity to grow into its valuation and beyond.

  • 10 stocks we like better than Palantir Technologies ›

One of the biggest hurdles for investors interested in buying Palantir Technologies (NASDAQ: PLTR) stock has been its high valuation. But it can overcome this by continuing to accelerate its revenue growth and grow into that valuation.

While the stock price sank following its Q1 results, the company once again showed accelerated revenue growth in the quarter and raised its revenue outlook for the year. However, with a high valuation comes high expectations, and while it was a very strong report, it wasn't perfect.

Artist rendering of AI brain.
Image source: Getty Images.

Accelerating revenue growth

The first quarter of 2025 marked the seventh straight time that Palantir has seen its quarterly revenue growth accelerate. During that span, growth increased from 13% in fiscal 2023's Q2 to 39% last quarter. Meanwhile, its Q1 revenue of $883.9 million easily surpassed management's forecast of $858 million to $862 million.

Metric

Q2 '23

Q3 '23

Q4 '24

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Revenue growth

13%

17%

20%

21%

27%

30%

36%

39%

Source: Palantir quarterly reports.

Palantir's artificial intelligence platform (AIP) continues to be its primary growth driver, particularly with U.S. commercial customers. The company credited AIP's ontology, or the operational layer for AI that connects digital assets (data sets and models) to their real-world counterparts (products or orders).

It said AIP is entering its next phase of production, in which customers can use its platform to create AI agents to help drive enterprise autonomy. It cited examples of insurance giant AIG using AI underwriting agents built on its platform, as well as a hospital, Tampa General, using AI agents to monitor for sepsis. It also noted that customers are starting to expand rapidly, quickly moving on from boot camps or pilots to sign multi-year contracts.

As a result, U.S. commercial revenue soared 71% to $255 million in the quarter. Meanwhile, its U.S. commercial remaining deal value, which refers to revenue it will recognize in the future from contracts already signed, surged 127% to $2.32 billion.

On the government side of its business, revenue climbed 45% year over year to $487 million. U.S. government revenue increased by 45% to $373 million. The company said it remained confident that it was well-positioned to navigate the current federal budget cuts, noting that this should highlight the value of its offerings. Therefore, it expects to garner bigger budget allocations within the Department of Defense and other agencies.